RT Journal Article SR Electronic T1 Transmitted HIV-1 is more pathogenic in heterosexual individuals than homosexual men JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.09.08.20191015 DO 10.1101/2020.09.08.20191015 A1 Ananthu James A1 Narendra M. Dixit YR 2020 UL http://medrxiv.org/content/early/2020/09/09/2020.09.08.20191015.abstract AB Transmission bottlenecks introduce selection pressures on HIV-1 that vary substantially with the mode of transmission. Recent studies on small cohorts have suggested that stronger selection pressures lead to fitter transmitted/founder (T/F) strains. Manifestations of this selection bias at the population level have remained elusive. Here, we analysed early CD4 cell count measurements reported from ∼340,000 infected heterosexual individuals (HSX) and men-who-have-sex-with-men (MSM), across geographies, ethnicities and calendar years and found them to be consistently lower in HSX than MSM (P<0.05). The corresponding average reduction in CD4 counts relative to healthy adults was 86.5% in HSX and 67.8% in MSM (P<10−4). This difference could not be attributed to differences in age, HIV-1 subtype, viral load, gender, ethnicity, time of transmission, or diagnosis delay across the groups. We concluded that the different selection pressures arising from the different predominant transmission modes have resulted in more pathogenic T/F strains in HSX than MSM.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the DBT/Wellcome Trust India Alliance Senior Fellowship IA/S/14/1/501307 (NMD). The funders had no role in the study design, execution, analysis, or manuscript preparation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is a meta-analysis and no approvals were required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used in the study has been previously published. The sources are indicated in the manuscript. No new data is generated as part of this study.